StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.21+0.01 (+6.06%)

Close on Nov 17, 2026Market cap $947.51KP/E –Yield –

Oragenics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Oragenics's operating cash flow for the twelve months ending Jun 30, 2026 was -$10.21M. For fiscal 2025 it was -$9.25M. The highest annual figure on record is -$5.19M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.25M–
FY2024Dec 31, 2024-$8.60M–
FY2023Dec 31, 2023-$7.29M–
FY2022Dec 31, 2022-$15.23M–
FY2021Dec 31, 2021-$13.47M–
FY2020Dec 31, 2020-$16.95M–
FY2019Dec 31, 2019-$13.01M–
FY2018Dec 31, 2018-$9.08M–
FY2017Dec 31, 2017-$6.36M–
FY2016Dec 31, 2016-$7.08M–
FY2015Dec 31, 2015-$5.19M–
FY2014Dec 31, 2014-$5.56M–
FY2013Dec 31, 2013-$6.76M–
FY2012Dec 31, 2012-$5.21M–
FY2011Dec 31, 2011-$5.49M–
FY2010Dec 31, 2010-$6.45M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.19M–
Q1 FY2026Mar 31, 2026-$2.20M–
Q4 FY2025Dec 31, 2025-$2.84M–
Q3 FY2025Sep 30, 2025-$2.98M–
Q2 FY2025Jun 30, 2025-$1.31M–
Q1 FY2025Mar 31, 2025-$2.11M–
Q4 FY2024Dec 31, 2024-$2.02M–
Q3 FY2024Sep 30, 2024-$1.97M–
Q2 FY2024Jun 30, 2024-$1.54M–
Q1 FY2024Mar 31, 2024-$3.06M–
Q4 FY2023Dec 31, 2023-$1.10M–
Q3 FY2023Sep 30, 2023-$1.50M–
Q2 FY2023Jun 30, 2023-$2.58M–
Q1 FY2023Mar 31, 2023-$2.11M–
Q4 FY2022Dec 31, 2022-$2.43M–
Q3 FY2022Sep 30, 2022-$3.78M–
Q2 FY2022Jun 30, 2022-$3.38M–
Q1 FY2022Mar 31, 2022-$5.64M–
Q4 FY2021Dec 31, 2021-$2.48M–
Q3 FY2021Sep 30, 2021-$4.58M–
Q2 FY2021Jun 30, 2021-$2.08M–
Q1 FY2021Mar 31, 2021-$4.33M–
Q4 FY2020Dec 31, 2020-$3.63M–
Q3 FY2020Sep 30, 2020-$4.67M–
Q2 FY2020Jun 30, 2020-$4.83M–
Q1 FY2020Mar 31, 2020-$3.82M–
Q4 FY2019Dec 31, 2019-$3.94M–
Q3 FY2019Sep 30, 2019-$3.38M–
Q2 FY2019Jun 30, 2019-$3.49M–
Q1 FY2019Mar 31, 2019-$2.21M–
Q4 FY2018Dec 31, 2018-$2.98M–
Q3 FY2018Sep 30, 2018-$2.45M–
Q2 FY2018Jun 30, 2018-$2.28M–
Q1 FY2018Mar 31, 2018-$1.37M–
Q4 FY2017Dec 31, 2017-$1.36M–
Q3 FY2017Sep 30, 2017-$1.34M–
Q2 FY2017Jun 30, 2017-$1.77M–
Q1 FY2017Mar 31, 2017-$1.90M–
Q4 FY2016Dec 31, 2016-$1.96M–
Q3 FY2016Sep 30, 2016-$1.57M–

More Oragenics figures

See a number that looks wrong?